Premenstrual Dysphoric Disorder (PMDD) -- Diagnosis and Treatment

What Is Premenstrual Dysphoric Disorder?

Premenstrual Dysphoric Disorder (PMDD) is a severe, cyclical mood disorder linked to the luteal phase of the menstrual cycle -- the one to two weeks between ovulation and the start of menstruation. It is characterized by marked emotional, behavioral, and physical symptoms that significantly impair functioning and relationships, and that remit within a few days of menstrual onset.

PMDD was formally recognized in the DSM-5 as a distinct depressive disorder, not merely a variant of PMS. This distinction matters clinically: PMDD is not about physical discomfort or mild irritability -- it involves psychiatric symptoms of sufficient severity to disrupt work, relationships, and daily functioning for a substantial portion of every month. Women with PMDD lose, on average, approximately one week per month to symptom-driven impairment over their reproductive years.

In my practice, I regularly see patients from San Diego and Southern California who have been experiencing PMDD for years -- sometimes decades -- without a clear diagnosis. They have been told it is "just hormones," prescribed oral contraceptives that helped only partially, or treated for anxiety and depression that was actually PMDD. The cyclical, predictable pattern is the key to diagnosis -- and once identified, the treatment response is often dramatic.

Signs and Symptoms of PMDD

PMDD symptoms must be present in the luteal phase, absent or minimal in the follicular phase, and confirmed prospectively over at least two menstrual cycles. The DSM-5 requires at least five symptoms, including at least one of the core mood symptoms.

Understanding the PMDD Cycle

The defining feature of PMDD -- and the one that distinguishes it from other mood disorders -- is its tight relationship with the menstrual cycle. Understanding this pattern is essential both for diagnosis and for helping patients make sense of their own experience.

PMDD vs PMS vs Premenstrual Magnification

PMS (Premenstrual Syndrome) involves physical and mild emotional symptoms in the luteal phase that are bothersome but do not significantly impair functioning. PMS is extremely common -- affecting up to 75% of women to some degree -- and typically does not require psychiatric treatment. PMDD, by contrast, involves symptoms severe enough to substantially impair work, relationships, or daily activities, and meets criteria for a DSM-5 mood disorder diagnosis.

Premenstrual Magnification (PMME) is a critically important distinction that changes the treatment approach entirely. In PMME, an underlying psychiatric condition -- depression, anxiety, bipolar disorder, or ADHD -- is present throughout the cycle but worsens significantly in the luteal phase. The pattern looks like PMDD superficially, but there is no true symptom-free follicular phase. Treating PMME as PMDD will produce only partial results -- the underlying condition must be identified and treated first.

I also carefully assess for PMDD in the context of perimenopause, where hormonal fluctuations can precipitate or worsen PMDD-like symptoms in women in their 40s who may have had well-controlled PMDD previously. The approach to perimenopausal PMDD requires coordination with gynecology and a different hormonal consideration framework.

Getting a Proper Diagnosis

PMDD diagnosis requires more than a clinical interview -- it requires prospective documentation of the symptom pattern over at least two menstrual cycles. In my practice, I ask patients to begin daily symptom tracking using the Daily Record of Severity of Problems (DRSP) before the first visit, or I provide it at the initial evaluation for prospective confirmation over the following two cycles.

The evaluation also includes a thorough assessment to distinguish PMDD from PMME -- ruling out underlying depression, anxiety, bipolar disorder, or ADHD that is being magnified in the luteal phase. Medical conditions that vary with the menstrual cycle -- thyroid dysfunction, migraine, autoimmune conditions -- are also considered when the clinical picture is ambiguous.

I coordinate with gynecology when hormonal management is part of the treatment strategy, and I discuss the interaction between any existing contraceptive methods and the proposed psychiatric treatment approach.

Treatment at Our Practice

PMDD has among the highest treatment response rates of any mood disorder. The majority of patients achieve significant symptom reduction with the right approach -- and because the condition is so predictable, treatment can be tailored with precision.

First-line medication -- SSRIs: SSRIs are uniquely effective for PMDD and work faster than in depression, often producing response within days rather than weeks. This has led to an approved intermittent dosing strategy: SSRIs taken only during the luteal phase (from ovulation to menstrual onset) are as effective as continuous daily dosing for PMDD, and significantly reduce cumulative side effect exposure. Fluoxetine, sertraline, and paroxetine all have FDA approval specifically for PMDD. I discuss continuous versus intermittent dosing based on the severity and pattern of your symptoms.

Hormonal approaches: GnRH agonists (leuprolide) suppress ovulation and eliminate the hormonal cycling that drives PMDD, with high efficacy but significant side effects requiring add-back estrogen. Combined oral contraceptives -- particularly drospirenone-containing formulations (Yaz) -- have evidence for PMDD and are a reasonable option for patients who prefer a hormonal approach or who need contraception. I coordinate with gynecology for hormonal management when indicated.

Psychotherapy: Cognitive Behavioral Therapy adapted for PMDD helps patients anticipate and manage the luteal phase more effectively, restructure catastrophic cognitions that emerge during symptomatic periods, and communicate with partners and colleagues about the condition. I coordinate referrals to bilingual CBT therapists in the Tijuana-San Diego region.

Follow-up visits are $95 USD and can be conducted via telepsychiatry for established patients when clinically appropriate and where legally permitted.

PMDD Care for California Residents

PMDD is one of the conditions most consistently undertreated in primary care -- because most OB-GYNs and primary care physicians are not trained in the psychiatric management of mood disorders, and most psychiatrists are not accustomed to thinking cyclically. Patients from San Diego, Chula Vista, National City, and Oceanside frequently arrive having been told their symptoms are "just hormones" or having received oral contraceptives that addressed the physical symptoms without touching the psychiatric ones.

At New City Medical Plaza, Paseo del Centenario 9580, Piso 25, Zona Urbana Rio Tijuana -- approximately 20 minutes from the San Ysidro border crossing -- you receive a thorough psychiatric evaluation specifically oriented to the cyclical pattern of PMDD. We accept cash, credit cards, Zelle, and Venmo. SSRIs for PMDD are available at Tijuana pharmacies at significantly lower prices than in the US.

Frequently Asked Questions

Related Conditions